RAD51 and BRCA2 enhance oncolytic adenovirus type 5 activity in ovarian cancer. (July 2016) - Tookman, L.; Ashley, B.; Connell, C.; Bridge, G.; Ingemarsdotter, C.; Dowson, S.; Shibata, A.; Michelle, L.; Martin, S.; McNeish, I.